The disease management blog's last two posts were long, so some brevity and levity are called for. With apologies to the authors of the original versions:
Question: Just why are actuaries so smart?
Answer: While in most humans, one side of the brain is slightly larger than the other, in actuaries each side of the brain is larger than the other.
Question: What is the definition of a double blind clinical trial?
Answer: Any research involving two disease management companies.
Question: What is the definition of a well run, randomized, multi-level cluster-design prospective cohort trial using comprehensive regression analytic methodologies to adequately control for confounders?
Answer: Heck I don't know, and neither does CMS.
Question: What is the motto of the disease management industry?
Answer: "We talk. You listen. They pay."
Question: What is the motto of integrated delivery system-run disease management programs?
Answer: "We talk. We pay. Ourselves lots."
Question: What is the one thing health services researchers and health economists have in common?
Answer: Both wish they could be as smart as the actuaries.
Question: When it comes to payor methodologies, what is the one key difference between dirt and primary care?
Answer: No one goes out of their way to step on dirt.
No comments:
Post a Comment